diacerein has been researched along with Cardiac Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, G; Liang, G; Liang, S; Luo, W; Sun, J; Wang, M; Yu, T; Zou, C | 1 |
| Belli, B; Fascetti, P; Gentilini, P; La Villa, G; Laffi, G; Marra, F; Meacci, E | 1 |
1 trial(s) available for diacerein and Cardiac Failure
| Article | Year |
|---|---|
Effects of rhein on renal arachidonic acid metabolism and renal function in patients with congestive heart failure.
Topics: 6-Ketoprostaglandin F1 alpha; Aged; Aged, 80 and over; Aldosterone; Anthraquinones; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acids; Cyclooxygenase Inhibitors; Dinoprostone; Double-Blind Method; Female; Heart Failure; Humans; Kidney; Kidney Function Tests; Renin | 1989 |
1 other study(ies) available for diacerein and Cardiac Failure
| Article | Year |
|---|---|
Diacerein alleviates Ang II-induced cardiac inflammation and remodeling by inhibiting the MAPKs/c-Myc pathway.
Topics: Angiotensin II; Animals; Anthraquinones; Cardiomegaly; Cardiomyopathies; Fibrosis; Heart Failure; Hypertension; Inflammation; Mice; Mice, Inbred C57BL; Myocardium; Myocytes, Cardiac; RNA; Ventricular Remodeling | 2022 |